Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review

被引:17
作者
Hsiao, S. -H. [2 ]
Chen, H. -H. [3 ]
Chou, C. -H. [2 ]
Lin, W. -L. [2 ]
Liu, P. -Y. [2 ]
Wu, T. -J. [1 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 704, Taiwan
[2] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan 70428, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan
关键词
cross-reactivity; drug hypersensitivity syndrome; neutropenia; teicoplanin; vancomycin;
D O I
10.1111/j.1365-2710.2009.01124.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypersensitivity syndrome associated with teicoplanin has rarely been reported. We report a case with a preceding episode of vancomyin-related neutropenia. A 47-year-old female with cervical spine infection was treated with vancomycin. Neutropenia occurred after 17 days of vancomycin therapy. Vancomycin was changed to teicoplanin, and the neutropenia resolved 4 days later. After 11 days of teicoplanin therapy, a new episode of hypersensitivity syndrome manifested as fever, bilateral neck lymphadenopathy, mild wheezing, hepatitis and increased CRP occurred. Neutropenia and thrombocytopenia developed 3 days later. The patient's symptoms settled over 1 week following withdrawal of teicoplanin. Naranjo's ADR algorithm categorized the neutropenia associated with vancomycin and the hypersensitivity syndrome associated with teicoplanin as 'probable'.
引用
收藏
页码:729 / 732
页数:4
相关论文
共 18 条
[1]  
Descamps V, 2001, ARCH DERMATOL, V137, P301
[2]   RETROSPECTIVE STUDY OF THE TOXICITY OF PREPARATIONS OF VANCOMYCIN FROM 1974 TO 1981 [J].
FARBER, BF ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :138-141
[3]  
Ghislain Pierre-Dominique, 2002, Dermatol Online J, V8, P5
[4]   THE ANTICONVULSANT HYPERSENSITIVITY SYNDROME [J].
HANDFIELDJONES, SE ;
JENKINS, RE ;
WHITTAKER, SJ ;
BESSE, CP ;
MCGIBBON, DH .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :175-177
[5]   A case of hypersensitivity syndrome to both vancomycin and teicoplanin [J].
Kwon, Hyouk-Soo ;
Chang, Yoon-Seok ;
Jeong, Yi-Yeong ;
Lee, Sang-Min ;
Song-, Woo-Jung ;
Kim, Hong-Bin ;
Kim, Yoon-Keun ;
Cho, Sang-Heon ;
Kim, You-Young ;
Min, Kyung-Up .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2006, 21 (06) :1108-1110
[6]   Teicoplanin hypersensitivity syndrome [J].
Lye, David ;
Athan, Eugene ;
O'Brien, Daniel .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (04) :476-478
[7]   HIGH-INCIDENCE OF VANCOMYCIN-ASSOCIATED LEUKOPENIA AND NEUTROPENIA IN A CARDIOTHORACIC SURGICAL UNIT [J].
MORRIS, A ;
WARD, C .
JOURNAL OF INFECTION, 1991, 22 (03) :217-223
[8]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[9]   Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy [J].
Pai, MP ;
Mercier, RC ;
Koster, SA .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) :224-228
[10]   Drug points: Teicoplanin induced drug hypersensitivity syndrome [J].
Perrett, CM ;
McBride, SR .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7451) :1292-1292